vs
EVgo Inc.（EVGO）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
EVgo Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$118.5M vs $75.5M），EVgo Inc.同比增速更快（75.5% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-38.1M），过去两年EVgo Inc.的营收复合增速更高（46.6% vs 31.3%）
EVgo Inc.是美国知名的电动汽车快充网络运营商，截至2023年8月，公司已布局超过950个充电站点，覆盖美国35个州，旗下充电桩兼容全球各大主流车企的电动汽车。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
EVGO vs PBYI — 直观对比
营收规模更大
EVGO
是对方的1.6倍
$75.5M
营收增速更快
EVGO
高出47.8%
27.7%
自由现金流更多
PBYI
多$52.5M
$-38.1M
两年增速更快
EVGO
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.5M | $75.5M |
| 净利润 | $-4.8M | — |
| 毛利率 | 38.0% | 69.3% |
| 营业利润率 | -10.4% | 22.7% |
| 净利率 | -4.1% | — |
| 营收同比 | 75.5% | 27.7% |
| 净利润同比 | 61.1% | — |
| 每股收益（稀释后） | $-0.03 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVGOPBYI
| Q4 25 | $118.5M | $75.5M | ||
| Q3 25 | $92.3M | $54.5M | ||
| Q2 25 | $98.0M | $52.4M | ||
| Q1 25 | $75.3M | $46.0M | ||
| Q4 24 | $67.5M | $59.1M | ||
| Q3 24 | $67.5M | $80.5M | ||
| Q2 24 | $66.6M | $47.1M | ||
| Q1 24 | $55.2M | $43.8M |
净利润EVGOPBYI
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-12.4M | $8.8M | ||
| Q2 25 | $-13.0M | $5.9M | ||
| Q1 25 | $-11.4M | $3.0M | ||
| Q4 24 | $-12.4M | — | ||
| Q3 24 | $-11.7M | $20.3M | ||
| Q2 24 | $-10.4M | $-4.5M | ||
| Q1 24 | $-9.8M | $-4.8M |
毛利率EVGOPBYI
| Q4 25 | 38.0% | 69.3% | ||
| Q3 25 | 13.6% | 77.7% | ||
| Q2 25 | 14.2% | 76.5% | ||
| Q1 25 | 12.4% | 77.1% | ||
| Q4 24 | 14.5% | 76.4% | ||
| Q3 24 | 9.4% | 63.9% | ||
| Q2 24 | 9.6% | 77.4% | ||
| Q1 24 | 12.4% | 75.5% |
营业利润率EVGOPBYI
| Q4 25 | -10.4% | 22.7% | ||
| Q3 25 | -36.9% | 17.6% | ||
| Q2 25 | -31.4% | 12.7% | ||
| Q1 25 | -44.4% | 8.7% | ||
| Q4 24 | -51.9% | 22.6% | ||
| Q3 24 | -47.1% | 27.4% | ||
| Q2 24 | -48.6% | -4.6% | ||
| Q1 24 | -58.7% | -5.3% |
净利率EVGOPBYI
| Q4 25 | -4.1% | — | ||
| Q3 25 | -13.4% | 16.2% | ||
| Q2 25 | -13.3% | 11.2% | ||
| Q1 25 | -15.1% | 6.5% | ||
| Q4 24 | -18.4% | — | ||
| Q3 24 | -17.3% | 25.2% | ||
| Q2 24 | -15.6% | -9.6% | ||
| Q1 24 | -17.8% | -11.0% |
每股收益（稀释后）EVGOPBYI
| Q4 25 | $-0.03 | $0.26 | ||
| Q3 25 | $-0.09 | $0.17 | ||
| Q2 25 | $-0.10 | $0.12 | ||
| Q1 25 | $-0.09 | $0.06 | ||
| Q4 24 | $-0.11 | $0.40 | ||
| Q3 24 | $-0.11 | $0.41 | ||
| Q2 24 | $-0.10 | $-0.09 | ||
| Q1 24 | $-0.09 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.0M | $97.5M |
| 总债务越低越好 | $206.5M | $22.7M |
| 股东权益账面价值 | $-116.9M | $130.3M |
| 总资产 | $964.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资EVGOPBYI
| Q4 25 | $151.0M | $97.5M | ||
| Q3 25 | $181.3M | $94.4M | ||
| Q2 25 | $154.5M | $96.0M | ||
| Q1 25 | $150.0M | $93.2M | ||
| Q4 24 | $117.3M | $101.0M | ||
| Q3 24 | $141.9M | $96.7M | ||
| Q2 24 | $162.3M | $96.8M | ||
| Q1 24 | $175.1M | $107.2M |
总债务EVGOPBYI
| Q4 25 | $206.5M | $22.7M | ||
| Q3 25 | $157.3M | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益EVGOPBYI
| Q4 25 | $-116.9M | $130.3M | ||
| Q3 25 | $-428.1M | $115.3M | ||
| Q2 25 | $-230.1M | $104.7M | ||
| Q1 25 | $-36.8M | $97.1M | ||
| Q4 24 | $-256.1M | $92.1M | ||
| Q3 24 | $-344.8M | $71.1M | ||
| Q2 24 | $13.6M | $48.5M | ||
| Q1 24 | $25.7M | $51.0M |
总资产EVGOPBYI
| Q4 25 | $964.8M | $216.3M | ||
| Q3 25 | $931.8M | $202.9M | ||
| Q2 25 | $864.7M | $194.9M | ||
| Q1 25 | $856.0M | $196.2M | ||
| Q4 24 | $803.8M | $213.3M | ||
| Q3 24 | $791.7M | $220.7M | ||
| Q2 24 | $785.3M | $205.0M | ||
| Q1 24 | $787.5M | $214.1M |
负债/权益比EVGOPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-38.1M | $14.4M |
| 自由现金流率自由现金流/营收 | -32.2% | 19.1% |
| 资本支出强度资本支出/营收 | 41.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-124.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流EVGOPBYI
| Q4 25 | $11.3M | $14.4M | ||
| Q3 25 | $-22.8M | $9.7M | ||
| Q2 25 | $14.1M | $14.1M | ||
| Q1 25 | $-10.2M | $3.6M | ||
| Q4 24 | $-12.8M | $15.6M | ||
| Q3 24 | $12.1M | $11.0M | ||
| Q2 24 | $7.6M | $1.0M | ||
| Q1 24 | $-14.1M | $11.2M |
自由现金流EVGOPBYI
| Q4 25 | $-38.1M | $14.4M | ||
| Q3 25 | $-49.0M | $9.7M | ||
| Q2 25 | $-12.1M | $14.1M | ||
| Q1 25 | $-25.2M | $3.6M | ||
| Q4 24 | $-36.5M | $15.6M | ||
| Q3 24 | $-13.7M | $11.0M | ||
| Q2 24 | $-16.6M | $1.0M | ||
| Q1 24 | $-35.2M | — |
自由现金流率EVGOPBYI
| Q4 25 | -32.2% | 19.1% | ||
| Q3 25 | -53.1% | 17.7% | ||
| Q2 25 | -12.4% | 26.8% | ||
| Q1 25 | -33.5% | 7.7% | ||
| Q4 24 | -54.1% | 26.4% | ||
| Q3 24 | -20.3% | 13.7% | ||
| Q2 24 | -25.0% | 2.1% | ||
| Q1 24 | -63.7% | — |
资本支出强度EVGOPBYI
| Q4 25 | 41.7% | 0.0% | ||
| Q3 25 | 28.3% | 0.0% | ||
| Q2 25 | 26.7% | 0.0% | ||
| Q1 25 | 19.9% | 0.1% | ||
| Q4 24 | 35.1% | 0.0% | ||
| Q3 24 | 38.3% | 0.0% | ||
| Q2 24 | 36.3% | 0.0% | ||
| Q1 24 | 38.2% | 0.0% |
现金转化率EVGOPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVGO
| Charging Network Revenue | $63.6M | 54% |
| Charging Revenue Retail | $35.8M | 30% |
| Charging Revenue Commercial | $9.3M | 8% |
| Charging Revenue Oem | $6.5M | 6% |
| Regulatory Credit Sales | $2.2M | 2% |
PBYI
暂无分部数据
